Loading...
Loading...
EOLS| Name | Value |
|---|---|
| Revenues | 61.0M |
| Cost of Revenue | 20.6M |
| Gross Profit | 40.4M |
| Operating Expense | 45.4M |
| Operating I/L | -5.1M |
| Other Income/Expense | -3.1M |
| Interest Income | 0.3M |
| Pretax | -11.7M |
| Income Tax Expense | 0.1M |
| Net Income/Loss | -11.8M |
Evolus, Inc. is a performance beauty company that provides medical aesthetic products, primarily focusing on Jeuveau, a botulinum toxin type A formulation for improving the appearance of glabellar lines in adults. The company generates revenue by selling Jeuveau to physicians for use in their patients' aesthetic treatments.
